HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: db08-0593v1 57/10/2619    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Forouhi, N. G. Articles by Wareham, N. J. PubMed PubMed Citation Articles by Forouhi, N. G. Articles by Wareham, N. J. Related Collections Related Article Social Bookmarking                What's this?

Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance

The Medical Research Council Ely Prospective Study 1990–2000

¹ Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Cambridge, U.K
² Centre for Diabetes and Metabolic Medicine, Bart's and the London School of Medicine and Dentistry, London, U.K

Corresponding author: Dr. Nita Gandhi Forouhi, nf250{at}medschl.cam.ac.uk

OBJECTIVE—Accumulating epidemiological evidence suggests that hypovitaminosis D may be associated with type 2 diabetes and related metabolic risks. However, prospective data using the biomarker serum 25-hydroxyvitamin D [25(OH)D] are limited and therefore examined in the present study.

RESEARCH DESIGN AND METHODS—A total of 524 randomly selected nondiabetic men and women, aged 40–69 years at baseline, with measurements for serum 25(OH)D and IGF-1 in the population-based Ely Study, had glycemic status (oral glucose tolerance), lipids, insulin, anthropometry, and blood pressure measured and metabolic syndrome risk (metabolic syndrome z score) derived at baseline and at 10 years of follow-up.

RESULTS—Age-adjusted baseline mean serum 25(OH)D was greater in men (64.5 nmol/l [95% CI 61.2–67.9]) than women (57.2 nmol/l [54.4,60.0]) and varied with season (highest late summer). Baseline 25(OH)D was associated inversely with 10-year risk of hyperglycemia (fasting glucose: β = –0.0023, P = 0.019; 2-h glucose: β = –0.0097, P = 0.006), insulin resistance (fasting insulin β = –0.1467, P = 0.010; homeostasis model assessment of insulin resistance [HOMA-IR]: β = –0.0059, P = 0.005), and metabolic syndrome z score (β = –0.0016, P = 0.048) after adjustment for age, sex, smoking, BMI, season, and baseline value of each metabolic outcome variable. Associations with 2-h glucose, insulin, and HOMA-IR remained significant after further adjustment for IGF-1, parathyroid hormone, calcium, physical activity, and social class.

CONCLUSIONS—This prospective study reports inverse associations between baseline serum 25(OH)D and future glycemia and insulin resistance. These associations are potentially important in understanding the etiology of abnormal glucose metabolism and warrant investigation in larger, specifically designed prospective studies and randomized controlled trials of supplementation.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article:

Vitamin D and Type 2 Diabetes: Are We Ready for a Prevention Trial?

Robert Scragg
Diabetes 2008 57: 2565-2566. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				R. Scragg Vitamin D and Type 2 Diabetes: Are We Ready for a Prevention Trial? Diabetes, October 1, 2008; 57(10): 2565 - 2566. [Full Text] [PDF]